These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 844692

  • 1. Cephalexin: clinical effectiveness in geriatric patients.
    Smith IM.
    Geriatrics; 1977 Mar; 32(3):91-5, 99. PubMed ID: 844692
    [Abstract] [Full Text] [Related]

  • 2. [Clinical trial in patients with infectious diseases of a new injectable cephalosporin derivative: lysine salt of cephalexin].
    Restivo O, Caruso R.
    Arch Maragliano Patol Clin; 1976 Mar; 32():37-45. PubMed ID: 1053292
    [No Abstract] [Full Text] [Related]

  • 3. Cefaclor--summary of clinical experience.
    Kammer RB, Short LJ.
    Postgrad Med J; 1979 Mar; 55 Suppl 4():93-9. PubMed ID: 548945
    [Abstract] [Full Text] [Related]

  • 4. [Cephalexin in internal medicine. Antibacterial treatment in 30 patients, 10 of them with malignant hemopathies, including 6 cases of agranulocytosis (granulocytes 1500/mm3)].
    Mizon JP, Gentit F.
    Lille Med; 1975 Jan; 20(1):58-60. PubMed ID: 124374
    [No Abstract] [Full Text] [Related]

  • 5. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD, Schwartz R, Snow RM, Yarbrough DR.
    Clin Ther; 1991 Jan; 13(6):727-36. PubMed ID: 1790547
    [Abstract] [Full Text] [Related]

  • 6. The role of cephalexin in the treatment of skin and soft-tissue infections.
    Derrick CW, Reilly K.
    Postgrad Med J; 1983 Jan; 59 Suppl 5():43-6. PubMed ID: 6364089
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A, Humbert G, Borsa F, Bertrand A, Janbon F, Lafaix C, Beucler A, Veyssier P, Dusehu E, Modai J.
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [Abstract] [Full Text] [Related]

  • 8. Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: a review.
    Verhoef J.
    Clin Ther; 1988 May; 11 Suppl A():71-82. PubMed ID: 3072089
    [No Abstract] [Full Text] [Related]

  • 9. [Multicenter research on the clinical effectiveness and tolerability of an antibacterial drug. Results of 1063 cases].
    Privitera G, Bonino S, Del Mastro S.
    Clin Ter; 1982 Apr 30; 101(2):123-36. PubMed ID: 7094544
    [No Abstract] [Full Text] [Related]

  • 10. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA, Elston D, Akinlade BK, Weber K, Notario GF, Busman TA, Cifaldi M, Nilius AM.
    Curr Med Res Opin; 2006 Dec 30; 22(12):2419-28. PubMed ID: 17257456
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of the preparation Palitrex (cephalexin monohydrate)].
    Wojtacha-Wencel B, Urbańska D, Wojnar J.
    Wiad Lek; 1982 Jun 01; 35(6):385-90. PubMed ID: 7123926
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic efficacy of cefalexin in internal medicine].
    Lechi A, Cecchetin M.
    Clin Ter; 1972 Mar 15; 60(5):439-47. PubMed ID: 5038776
    [No Abstract] [Full Text] [Related]

  • 13. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.
    Speight TM, Brogden RN, Avery GS.
    Drugs; 1972 Mar 15; 3(1):9-78. PubMed ID: 4559812
    [No Abstract] [Full Text] [Related]

  • 14. Infections in the elderly: current concepts in management.
    Madhavan T.
    Compr Ther; 1994 Mar 15; 20(8):465-70. PubMed ID: 7956104
    [No Abstract] [Full Text] [Related]

  • 15. Cephalexin in lower respiratory tract infections.
    Raff MJ.
    Postgrad Med J; 1983 Mar 15; 59 Suppl 5():32-9. PubMed ID: 6364088
    [Abstract] [Full Text] [Related]

  • 16. [Clinical experience with cephalexin].
    Lasala FG, Mazzei CM, Castagneto H, Rechniewski C.
    Prensa Med Argent; 1971 Mar 12; 58(2):65-74. PubMed ID: 5091409
    [No Abstract] [Full Text] [Related]

  • 17. Netilmicin: chemical development and overview of clinical research.
    Herting RL, Lane AZ, Lorber RR, Wright JJ.
    Scand J Infect Dis Suppl; 1980 Mar 12; Suppl 23():20-9. PubMed ID: 7010547
    [Abstract] [Full Text] [Related]

  • 18. [Results of treatment with cefaclor, a new oral cephalosporin].
    Fortschr Med; 1979 Oct 11; 97(38):1709-10. PubMed ID: 511065
    [No Abstract] [Full Text] [Related]

  • 19. [Cephalexin (Oracef) in the ambulatory treatment of nonspecific urinary tract infections].
    Kaldewey W.
    MMW Munch Med Wochenschr; 1977 Jan 14; 119(2):63-4. PubMed ID: 401942
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
    Petrikkos G, Giamarellou H, Tsagaraki C, Pefanis A.
    J Chemother; 1995 Jun 14; 7 Suppl 2():161-4. PubMed ID: 8622106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.